copper peptide ghk-cu clinical trial skin anti-aging randomized Copper Peptide (GHK-Cu) 2% Recovery
Description
The transformics assay: first steps for the development of an integrated approach to investigate the malignant cell transformation in vitro
No relevant changes in the colloidal properties were observed after 24 hours storage, showing highly stable formulation
10 mg vial Concentration: 10 mg 3 mL = 3.333 mg/mL (equivalently 3,333 mcg/mL) Dose in mg: 600 mcg = 0.6 mg Draw volume: 0.6 mg 3.333 mg/mL = 0.18 mL Syringe units: 0.18 mL 100 = 18 units on a U-100 syringe So on the 10 mg vial, one documented dose is a draw to the 18-unit mark
We dont have FDA approval
And they dish it out in cosmetic clinics now
